Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Antithrombotic Therapy in Chronic Total Occlusion Interventions
Author(s): Iosif Xenogiannis , Charalampos Varlamos , Despoina-Rafailia Benetou , et al Added: 2 years ago

Intervention
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
Author(s): Leslie Marisol Lugo , Rafael Romaguera , Joan Antoni Gómez-Hospital , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is the therapy of choice for patients with symptomatic severe aortic stenosis who are unsuitable for surgical aortic valve replacement and for elderly patients with high operative risk.1,2 It is also considered to be a more than valid and reasonable alternative to surgical aortic valve replacement for patients with moderate to high surgical risk.3,4… View more

Anticoagulation
Antithrombotic Therapy in Complex PCI Patients Under OAC
Author(s): Despoina-Rafailia Benetou , Panayotis K Vlachakis , Charalampos Varlamos , et al Added: 2 years ago

Anticoagulation

Intervention
Dual Antithrombotic Therapy With Dabigatran
Author(s): Christopher P Cannon Added: 6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Anticoagulation
Antithrombotics in LM and Bifurcation PCI
Author(s): Charalampos Varlamos , Ioannis Lianos , Despoina-Rafailia Benetou , et al Added: 2 years ago

Intervention
ESC 22: COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts
Author(s): David Berg Added: 1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834). This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study… View more

Anticoagulation

Vascular Disease and Surgery
Antithrombotic Therapy after Percutaneous Coronary Intervention
Author(s): Darshni Arishta Jhagroe , Jur ten Berg Added: 3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical… View more

Anticoagulation

Intervention
Author(s): Gabriele Pesarini , Sara Ariotti , Flavio Ribichini Added: 3 years ago
Haemostasis is a complex phenomenon defined as the chain of mechanisms able to maintain the integrity of a closed, high-pressure circulatory system after vascular damage.1 Thrombogenesis represents the main process assuring haemostasis at each level of the vascular system, and its accurate regulation guarantees the correct balance between blood flow and damage repair. An uncontrolled thrombin… View more

MI/ACS

Intervention
Difficulties in Monitoring Antithrombotic Therapy in Patients with Atrial Fibrillation and Post-traumatic Hepatic and Splenic Visceral Haematomas
Author(s): Maria Cristina Beznă , Suzana Dănoiu , Marinela Beznă , et al Added: 12 months ago

Anticoagulation

Electrophysiology & Arrhythmia